Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Hisse Senetlerindeki Sıralama #1974
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Hisse Fiyatı
$177.09
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$10.45B
Değişim (1 gün)
1.76%
Değişim (1 yıl)
131.10%
Ülke
US
Ticaret Glaukos Corporation (GKOS)

Kategori

Healthcare
Glaukos Corporation (GKOS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $166.80 - 2026-10-01

Gün sonu en düşük fiyat: $29.05 - 2015-06-01
Glaukos Corporation için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.69 -18.50%
DE